bismuth subsalicylate

Adult Dosing .

Dosage forms:  CHEWABLE: 262 mg; SUSP: 262 mg per 15 mL

diarrhea, acute

[2 tabs PO q1h prn]

Max: 4200 mg/24h; Alt: 30 mL PO q1h prn

H. pylori infection (off-label)

[300 mg PO qid x14 days]

Info: part of multi-drug regimen; search 'H. pylori Tx' for epocrates H. pylori Tx Regimens decision tool

traveler's diarrhea prophylaxis (off-label)

[2 tabs PO qac and qhs]

Alt: 30 mL PO qac and qhs; Info: give for up to 3wk during period of risk

renal dosing

[see below]

mild-moderate impairment: not defined, caution advised; severe impairment: avoid use

HD/PD: not defined, caution advised

hepatic dosing

[not defined]

Peds Dosing .

Dosage forms:  CHEWABLE: 262 mg; SUSP: 262 mg per 15 mL

diarrhea, acute

[12 yo and older]

Dose: 2 tabs or 30 mL PO q1h prn; Max: 4200 mg/24h

H. pylori infection (off-label)

[<10 yo]

Dose: 1 tab PO qid x14 days; Alt: 15 mL PO qid x14 days; Info: part of multi-drug regimen; search 'H. pylori Tx' for epocrates H. pylori Tx Regimens decision tool

[10 yo and older]

Dose: 2 tabs PO qid x14 days; Alt: 30 mL PO qid x14 days; Info: part of multi-drug regimen; search 'H. pylori Tx' for epocrates H. pylori Tx Regimens decision tool

renal dosing

[see below]

mild-moderate impairment: not defined, caution advised; severe impairment: avoid use

HD/PD: not defined, caution advised

hepatic dosing

[not defined]